DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the HEALTHCARE GLOB. ENT. LTD (HCG) share price today?

HEALTHCARE GLOB. ENT. LTD (HCG) is trading at ₹655.85 on the NSE, down 0.64% on the day. Source: DocStoX.

What is the PE ratio of HEALTHCARE GLOB. ENT. LTD?

HEALTHCARE GLOB. ENT. LTD has a price-to-earnings (PE) ratio of 712.9 in the Healthcare sector.

What is the market capitalisation of HEALTHCARE GLOB. ENT. LTD?

HEALTHCARE GLOB. ENT. LTD has a market capitalisation of approximately ₹10,931 crore.

HEALTHCARE GLOB. ENT. LTD

HCG·NSE·Healthcare

₹655.85▼ -4.25 (-0.64%)

Healthcare · Hospitals

A steady, established business

Day₹652.80

₹664.80

52W₹513

₹80549%

Open

₹664.80

High

₹664.80

Low

₹652.80

Prev Close

₹660.10

Volume

73.2K

VWAP

₹655.87

Snapshot

Key fundamentals

Market Cap

₹10,931 Cr

P/E Ratio

712.88Expensive

P/B Ratio

7.28

EPS

₹0.92

Book Value

₹89.20

ROE

2.55%Weak

ROCE

8.00%Weak

Dividend Yield

0.00%

Debt / Equity

1.30Elevated

Face Value

₹10.00

52W High

₹804.65

52W Low

₹513.30

Sector

Healthcare

Industry

Hospitals

Avoid

None moatHigh uncertainty

Fair value estimate

₹69

▼ 89.5%downside

Trading at ₹656 — 90% above our estimate

BearFair valueBull

₹43₹69₹79

/100

Business quality — Watch the fundamentals

Growth 46Profitability 0Efficiency 0Valuation 18

Plain English

Our view

A steady, established business
Promoters hold a controlling stake
Weak returns on equity (3%)

Strengths

Promoters hold a controlling stake

Risks

Weak returns on equity (3%)
Expensive — trades at 713× earnings
Fundamental red flags (Piotroski 3/9)

How we got there

Fair value methods

Residual income

3% ROE fading to 14% over ~3 yrs, on ₹89 book

₹76

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹43

Analyst target

No analyst coverage

—

Blended fair value₹69

What the numbers say

Investment thesis

Bull case

Promoters hold a controlling stake

Bear case

Weak returns on equity (3%)
Expensive — trades at 713× earnings
Fundamental red flags (Piotroski 3/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

712.9Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

2.5%Weak

Above 15% is considered healthy for Indian equities

ROCE

8.0%Weak

Above 18% means capital is working hard

Debt/Eq

1.30Elevated

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹10,931 Cr

P/B

7.28

EPS

₹0.92

Div Yield

—

What changed

Recent changes

Domestic institutions+0.3% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 712.9×

Growth

Steady

+15% rev CAGR

Profitability

Modest

2.5% ROE

Financial health

Leveraged

D/E 1.30

Momentum

N/A

No technicals

Today

Trading activity

Delivery %59.1%

Turnover₹480.22L Cr

Trades6,978

VWAP₹655.87

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+14.6%

+20.3%

10Y

+15.9%

Profit

+8.5%

—

10Y

+27.7%

EPS

-22.7%

—

10Y

—

Profile

Cons

Stock is trading at 7.47 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Company has low interest coverage ratio.
Company has a low return on equity of 4.25% over last 3 years.
Promoter holding has decreased over last 3 years: -7.16%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions added 0.29 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

64%

Promoter

Promoters

64.2%0.00

Public

13.9%-0.29

FII / FPI

2.7%-0.03

DII

19.2%+0.29

Quarterly trend

Ownership over time

Q1 FY27

Promoter64.21%

FII2.73%

DII19.20%

Public13.86%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions